Superworth

Relay Therapeutics market cap RLAY

Share price times shares outstanding: what the whole company sells for, since 2020.

Today, Nov 2, 2026
$3.8B
Highest close in our data
$5.5B
Jan 2021

Relay Therapeutics is worth $3.8B at the close on Nov 2, 2026, at $17.28 a share.

That is up 261% over the last year and up 15% over five years.

Its highest close in our data was $5.5B in Jan 2021.

Market cap over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHighChange
2026 so far$3.8B$1.3B$4.4B+155%
2025$1.5B$339M$1.5B+103%
2024$729.8M$696.3M$1.4B−46%
2023$1.4B$740.1M$2.7B−25%
2022$1.8B$1.5B$3.5B−46%
2021$3.3B$2.6B$5.5B−11%
2020$3.7B$3.2B$4.8Bn/a

Against its peers

Companies in Biotechnology nearest Relay Therapeutics' size, closest first, today.

CompanyMarket cap
RLAYRelay Therapeutics$3.8B
ADMAAdma Biologics$2.5B
VCELVericel$2.1B
KRYSKrystal Biotech$8.8B
RGENRepligen$9.8B
TECHBIO-TECHNE$11.4B
HALOHalozyme Therapeutics$14.6B
NBIXNeurocrine Biosciences$14.8B
MGTXMeiraGTx$895.1M
EXELExelixis$17.4B
ALNYAlnylam Pharmaceuticals$21.2B
Peer median$10.6B

What the market cap tells you

Share price times shares outstanding: what the whole company sells for today.

Size, not quality. Large caps move slower and are covered more. That is all it tells you.

More on Relay Therapeutics

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.